Phocas Financial Corp’s BioTelemetry, Inc. BEAT Stock Holding History

Phocas Financial Corp’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-54,484	Closed	-$3.93M	–	220
2020 Q4	$3.93M	Sell	54,484 -11,081	-17%	-$580K	0.6%	71
2020 Q3	$2.99M	Buy	+65,565	New	+$2.74M	0.51%	84

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Phocas Financial Corp's BEAT Position: Q1 2021 in Review

Phocas Financial Corp sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 54,484 shares — an estimated $3.93M sold.

Phocas Financial Corp first reported a position in BEAT in Q3 2020 and held it in 2 quarters. The position peaked at $3.93M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Phocas Financial Corp reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Phocas Financial Corp sold 54,484 BioTelemetry, Inc. shares in Q1 2021, an estimated $3.93M.
Phocas Financial Corp first reported a position in BioTelemetry, Inc. in Q3 2020 and held it in 2 quarters.
Phocas Financial Corp's BioTelemetry, Inc. position peaked at $3.93M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Phocas Financial Corp's 13F filing for Q1 2021, filed 22 Jun 2021.